National Disease Research Interchange
National Disease Research Interchange
Providing human biospecimens to advance biomedical research and development worldwide.
Learn About UsNational Disease Research Interchange
2018 Service to Science Awards Dinner, February 1 at The Union League of Philadelphia
Review event recapNational Disease Research Interchange
Giving patients and families an opportunity to leave a meaningful legacy.
Consider DonatingNational Disease Research Interchange
Supporting breakthrough scientific discoveries with unmatched experience.
Review Our CapabilitiesNational Disease Research Interchange
Partnering with medical professionals to serve donor families and investigators.
Join our NetworkEvery year, NDRI distributes biospecimens to hundreds of investigators around the world who are working to advance many areas of science and healthcare. NDRI makes it easy for approved investigators to get much-needed biospecimens prepared, preserved and shipped precisely according the specific needs of the research protocol.
Request Process Request TissueResearchers continue to recognize NDRI as an invaluable partner as the need for human biomaterials grow. In response, NDRI has developed specialized programs to increase the supply of human tissues and organs for specific areas of research and has established a network of human tissue collection sites throughout the country to procure them.
Become a Partner See Our ProgramsThe National Disease Research Interchange (NDRI) has been awarded more than $800,000 by the National Institutes of Health (NIH). The supplemental awards provide support for NDRI to serve as a human biospecimen resource for research focused specifically on Alzheimer’s disease, Autism Spectrum Disorder (ASD) and HIV/AIDS. The three awards are supplements to NDRI’s Human Tissues and Organs for Research Resources (HTORR) program which has been supported by the NIH since 1987.
“Support from the NIH affirms the strong value of our mission,” said Gene Kopen, PhD, NDRI’s Senior Vice President for Strategic Initiatives and principal investigator for the HTORR grant. “As an organization, NDRI has demonstrated the capacity to leverage this support to enable a broad range of complex research projects requiring human organs and tissues.”
The Board of Directors and staff of National Disease Research Interchange (NDRI) celebrate the extraordinary life and unparalleled legacy of
D. Walter Cohen, DDS, who died on June 29, 2018 in Philadelphia.
The 2018 Warren Alpert Foundation Prize has been awarded to five scientists for transformative discoveries in the fields of genetics, physiology, pulmonology and pharmacology that have led to the development of life-altering precision-targeted treatments for the devastating multiorgan disease cystic fibrosis (CF).
Read NDRI's 2018 Research Nexus for a recap of our Service to Science Awards Dinner, an exciting update on programs and initiatives, and learn how NDRI investigators are accelerating scientific discoveries!
NDRI’s 2018 Service to Science Awards Salute Biomedical Research Partnerships
Meet NDRI's Patient Advoacacy and Foundations, Director at Global Genes October 3-5th in Irvine, CA!
Join NDRI's Site Management and Quality Leaders at the Annual AATb Meeting in Dallas, TX , October 9-12th!
NDRI's Strategic Initiatives leadership will be exhibiting at the North American Cystic Fibrosis Conference October 18-20 in Denver, CO!
Loading tweets...
NDRI is a Not-For-Profit (501c3) Corporation.
National Disease Research Interchange
8 Penn Center
15th Floor
1628 JFK Boulevard
Philadelphia, PA 19103
